SMITH BRAIN TRUST – It turns out, even the Oracle of Omaha has investment regrets. Famed investor and Berkshire Hathaway CEO Warren Buffett says he wishes he had bought shares early in some of the giants of tech, the so-called FAANG companies whose stocks have consistently outperformed the S&P.
Dr. David Kass has published articles in corporate finance, industrial organization, and health economics. He currently teaches Advanced Financial Management and Business Finance, and is the Faculty Champion for the Sophomore Finance Fellows. Prior to joining the faculty of the Smith School in 2004, he held senior positions with the Federal Government (Federal Trade Commission, General Accounting Office, Department of Defense, and the Bureau of Economic Analysis). Dr. Kass has recently appeared on Bloomberg TV, CNBC, PBS Nightly Business Report, Maryland Public Television, Business News Network TV (Canada), FOX TV, Bloomberg Radio, Wharton Business Radio, KCBS Radio, American Public Media's Marketplace Radio, and WYPR Radio (Baltimore), and has been quoted on numerous occasions by The Wall Street Journal, Bloomberg News, The New York Times and The Washington Post, where he has primarily discussed Warren Buffett, Berkshire Hathaway, the economy, and the stock market.
SMITH BRAIN TRUST – Shares of Lyft were still sagging days after the ride-hailing service had its initial public offering on the New York Stock Exchange. And that had Maryland Smith’s David Kass offering some advice.
In what’s poised to be a big year for big-name IPOs, Kass lists five reasons to ease up on the gas pedal and proceed with caution.
Beware the hype
SMITH BRAIN TRUST – Why would a company with a portfolio of brands seek to do a corporate spinoff?
SMITH BRAIN TRUST – Getting ready to hit the road or fly off somewhere for Thanksgiving? Maryland Smith faculty share their best travel hacks, from traveling early to the best ways to tolerate traffic, to make your holidays easier.
SMITH BRAIN TRUST – Pharmaceutical prices are poised to become a central issue for the next Congress, potentially forcing lawmakers to consider at least two factors that coincide with America’s higher-than-average drug prices.
The first is the lack of a governmental pharmaceutical price oversight board, similar to the ones that exist in Europe, Canada and the United Kingdom, where pharmaceutical companies typically charge far less for their products.
SMITH BRAIN TRUST – Whatever you thought about the midterm election results this week, you can say this much: The stock market was taking it all in stride, up more than 1 percent across the three major indexes.
The rally reflected a sigh of relief, says Maryland Smith’s David Kass. And it’s likely the start of a three-pronged rally that will continue through the next year.
SMITH BRAIN TRUST – If you follow tech industry news, by now you’ve heard that classic Silicon Valley startup story.
A few men have dropped out of college and are working in a garage when they strike a great idea. With total dedication to delivering on this idea, they launch a successful company. They create the most consumer-friendly personal computer on the market to date. They start Microsoft. They start Apple.